Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), a specialty pharmaceutical company, focuses their efforts on identifying, developing and commercializing innovative products designed to address unmet medical needs in neurology and psychiatry. Their goal as a company is to develop a broad portfolio of products through internal development and acquisition/in-licensing while utilizing a specialty sales force to promote products in target markets. For further information, visit the Company’s web site at www.jazzpharmaceuticals.com.
- 18 years ago
QualityStocks
Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Versus Systems Inc. (NASDAQ: VS) Powers Interactive Campaigns Across Sports, Entertainment and Media
Versus Systems (NASDAQ: VS) developed and operates a patented earned-rewards platform that enables brands, sports teams,…
-
QualityStocksNewsBreaks – Nightfood Holdings Inc. (OTCQB: NGTF) Signs LOI to Acquire Controlling Interest in Taiwan Automation Manufacturer
Nightfood Holdings (OTCQB: NGTF) doing business as TechForce Robotics, announced it has signed a non-binding letter of intent to acquire a…
-
QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Featured in BioMedWire Editorial on Multiple Sclerosis Treatment
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM)…